SEC ownership of Skye Bioscience, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001516551.

Comparable stake leader

5AM Partners VII, LLC

Disclosed value leader

5AM Partners VII, LLC

Comparable rows

50/50

Latest evidence

18 Aug 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
5AM Partners VII, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
18 Aug 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001516551
Issuer location
San Diego, CA

Ownership snapshot

Top shareholders of Skye Bioscience, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
5AM Partners VII, LLC
Disclosed value leader
5AM Partners VII, LLC
Comparable rows
50/50
Latest evidence
18 Aug 2026
13D/G 3/4/5 13F Lead comparable stake: 30% 13D/G row: 5AM Partners VII, LLC Showing 1-8 of 50 holder rows.

Quick read

5AM Partners VII, LLC leads the comparable SEC ownership view at 30%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens 5AM Partners VII, LLC's linked filing trail.
Comparable ownership Top 5
5AM Partners VII, LLC 30%
SPHERA FUNDS MANAGEMENT LTD. 4.8%
Schonfeld Strategic Advisors LLC 3.6%
5AM CO-INVESTORS II LP 25%
5AM Partners II, LLC 25%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
5AM Partners VII, LLC
13D/G 3/4/5
Andrew J. Schwab · 10%+ Owner
30%
$6,989,512
11,273,407 shares
-$166,104 14 Aug 2026
SPHERA FUNDS MANAGEMENT LTD.
13D/G 13F
Company
4.8%
$2,952,706
1,476,353 shares
$0 31 Mar 2025
Schonfeld Strategic Advisors LLC
13D/G
3.6%
$4,441,437
1,115,939 shares
-$1,996,997 30 Jun 2025
5AM CO-INVESTORS II LP
3/4/5
10%+ Owner
25%
$2,977,894
9,305,923 shares
-$140,313 18 Aug 2026
5AM Partners II, LLC
3/4/5
10%+ Owner
25%
$2,977,894
9,305,923 shares
-$140,313 18 Aug 2026
5AM Ventures II LP
3/4/5
10%+ Owner
25%
$2,977,894
9,305,923 shares
-$140,313 18 Aug 2026
5AM Ventures VII, L.P.
3/4/5
10%+ Owner
25%
$2,977,894
9,305,923 shares
-$140,313 18 Aug 2026
John D. Diekman
3/4/5
10%+ Owner
25%
$2,977,894
9,305,923 shares
-$140,313 18 Aug 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$1,262,817.

Buys
$0
Insiders: 0
Sells
$1,262,817
Insiders: 9
Net
-$1,262,817
Shares: -3,382,560
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 3,382,560
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 3,382,560 $0 $1,262,817 -$1,262,817
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 26 reporting-owner rows connected to Skye Bioscience, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
26
Largest Forms 3/4/5 holder
Versant Ventures III, LLC
Net 12M change
-$1,262,817
Latest report
18 Aug 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Versant Ventures III, LLC 10%+ Owner $9,386,012 Mixed 18 Aug 2023
Emerald Health Sciences Inc. 10%+ Owner $3,167,928 Mixed 10 Nov 2022
Kush Parmar 10%+ Owner $2,977,894 -$140,313 -4.5% Filing P/S 18 Aug 2026
5AM Ventures II LP 10%+ Owner $2,977,894 -$140,313 -4.5% Filing P/S 18 Aug 2026
5AM Partners II, LLC 10%+ Owner $2,977,894 -$140,313 -4.5% Filing P/S 18 Aug 2026
5AM Ventures VII, L.P. 10%+ Owner $2,977,894 -$140,313 -4.5% Filing P/S 18 Aug 2026
Andrew J. Schwab Director, 10%+ Owner $2,977,894 -$140,313 -4.5% Filing P/S 18 Aug 2026
John D. Diekman 10%+ Owner $2,977,894 -$140,313 -4.5% Filing P/S 18 Aug 2026
5AM CO-INVESTORS II LP 10%+ Owner $2,977,894 -$140,313 -4.5% Filing P/S 18 Aug 2026
Scott M. Rocklage 10%+ Owner $2,977,894 -$140,313 -4.5% Filing P/S 18 Aug 2026
5AM Partners VII, LLC 10%+ Owner $2,977,894 -$140,313 -4.5% Filing P/S 18 Aug 2026
Punit Dhillon Chief Executive Officer, Director $1,071,874 Mixed 07 Aug 2026
Kaitlyn Arsenault Chief Financial Officer $835,935 Filing P/S 06 Feb 2026
Christopher Twitty Chief Scientific Officer $147,251 Mixed 31 Mar 2026
Tuan Tu Diep Chief Operating Officer $2,880 Mixed 31 Mar 2026
John P. Sharp Chief Financial Officer Mixed 31 Mar 2026
Praveen Tyle Director Mixed 29 Feb 2024
Margaret Dalesandro Director Mixed 29 Feb 2024
Deborah H. Charych Director Mixed 31 Mar 2026
Keith Wayne Ward Director Mixed 29 Feb 2024

Recent insider transactions for Skye Bioscience, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Andrew J. Schwab SKYE Common Stock Sale -0.08% $2,078 $0.3200 -6,495 7,850,155 20 Aug 2026 By 5AM Ventures VII, L.P.
Andrew J. Schwab SKYE Common Stock Sale -0.08% $14.72 $0.3200 -46 55,208 20 Aug 2026 By 5AM Co-Investors II, L.P.
Andrew J. Schwab SKYE Common Stock Sale -0.08% $371 $0.3200 -1,159 1,400,560 20 Aug 2026 By 5AM Ventures II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $2,078 $0.3200 -6,495 7,850,155 20 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $2,078 $0.3200 -6,495 7,850,155 20 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $2,078 $0.3200 -6,495 7,850,155 20 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $2,078 $0.3200 -6,495 7,850,155 20 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $2,078 $0.3200 -6,495 7,850,155 20 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $2,078 $0.3200 -6,495 7,850,155 20 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $2,078 $0.3200 -6,495 7,850,155 20 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $2,078 $0.3200 -6,495 7,850,155 20 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $14.72 $0.3200 -46 55,208 20 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $14.72 $0.3200 -46 55,208 20 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $14.72 $0.3200 -46 55,208 20 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $14.72 $0.3200 -46 55,208 20 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $14.72 $0.3200 -46 55,208 20 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $14.72 $0.3200 -46 55,208 20 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $14.72 $0.3200 -46 55,208 20 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $14.72 $0.3200 -46 55,208 20 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $371 $0.3200 -1,159 1,400,560 20 Aug 2026 By 5AM Ventures II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $371 $0.3200 -1,159 1,400,560 20 Aug 2026 By 5AM Ventures II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $371 $0.3200 -1,159 1,400,560 20 Aug 2026 By 5AM Ventures II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $371 $0.3200 -1,159 1,400,560 20 Aug 2026 By 5AM Ventures II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $371 $0.3200 -1,159 1,400,560 20 Aug 2026 By 5AM Ventures II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $371 $0.3200 -1,159 1,400,560 20 Aug 2026 By 5AM Ventures II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $371 $0.3200 -1,159 1,400,560 20 Aug 2026 By 5AM Ventures II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.08% $371 $0.3200 -1,159 1,400,560 20 Aug 2026 By 5AM Ventures II, L.P.
Andrew J. Schwab SKYE Common Stock Sale -0.73% $20,117 $0.3500 -57,476 7,856,650 19 Aug 2026 By 5AM Ventures VII, L.P.
Andrew J. Schwab SKYE Common Stock Sale -0.73% $143 $0.3500 -409 55,254 19 Aug 2026 By 5AM Co-Investors II, L.P.
Andrew J. Schwab SKYE Common Stock Sale -0.73% $3,589 $0.3500 -10,255 1,401,719 19 Aug 2026 By 5AM Ventures II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $20,117 $0.3500 -57,476 7,856,650 19 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $20,117 $0.3500 -57,476 7,856,650 19 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $20,117 $0.3500 -57,476 7,856,650 19 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $20,117 $0.3500 -57,476 7,856,650 19 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $20,117 $0.3500 -57,476 7,856,650 19 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $20,117 $0.3500 -57,476 7,856,650 19 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $20,117 $0.3500 -57,476 7,856,650 19 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $20,117 $0.3500 -57,476 7,856,650 19 Aug 2026 By 5AM Ventures VII, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $143 $0.3500 -409 55,254 19 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $143 $0.3500 -409 55,254 19 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $143 $0.3500 -409 55,254 19 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $143 $0.3500 -409 55,254 19 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $143 $0.3500 -409 55,254 19 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $143 $0.3500 -409 55,254 19 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $143 $0.3500 -409 55,254 19 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $143 $0.3500 -409 55,254 19 Aug 2026 By 5AM Co-Investors II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $3,589 $0.3500 -10,255 1,401,719 19 Aug 2026 By 5AM Ventures II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $3,589 $0.3500 -10,255 1,401,719 19 Aug 2026 By 5AM Ventures II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $3,589 $0.3500 -10,255 1,401,719 19 Aug 2026 By 5AM Ventures II, L.P.
5AM Partners VII, LLC SKYE Common Stock Sale -0.73% $3,589 $0.3500 -10,255 1,401,719 19 Aug 2026 By 5AM Ventures II, L.P.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .